Group 1 - The company China High-Speed Transmission announced the proposal to dismiss Guo Wei as the auditor and appoint BDO as the new auditor, with the audit work for the 2025 financial statements expected to be completed by the end of May [1] - Due to the change in auditors, the company will not be able to comply with listing rules and publish regular financial information on time, leading to a suspension of trading from April 1 [1] - Recent board changes include the resignation of executive director Hu Yueming and non-executive director Ye Xingming, as well as independent non-executive director Jiang Jianhua, who resigned due to significant disagreements with current directors [1] Group 2 - The stock price of China High-Speed Transmission has dropped by 20.67%, with a cumulative decline of over 40% for the week, trading at 1.19 HKD with a transaction volume of 13.13 million HKD [2]

Recent Events - The company announced on February 12, 2026, the appointment of Ms. Wang Lei as the new Vice General Manager and Chief Financial Officer, following the resignation of HOO YONG KEONG and Jiang Aiping due to work adjustments [2] - The previous board meeting on February 10, 2026, also addressed the appointment of a new General Manager, indicating ongoing governance changes that may affect management stability, although specific business impacts were not disclosed [2] Stock Performance - Over the past week, the company's stock price showed slight fluctuations, closing at 8.48 yuan on February 13, 2026, with a daily decline of 0.47% and a cumulative increase of 2.54% from February 9 to February 13 [3] - The stock experienced a volatility range of 6.29%, with a net outflow of approximately 12.54 million yuan from institutional investors on February 13, while retail investors showed a net inflow [3] - The current price-to-earnings ratio (TTM) is negative, indicating pressure on profitability, yet the overall stock price movement remains moderate without signs of abnormal speculation [3]

Core Points - The sudden announcement of the death of Yin Zhenglong, the controlling shareholder and chairman of Shanhe Pharmaceutical Excipients, occurred on August 26, 2025, at the age of 60 [1][5][7] - Yin Zhenglong held 63,057,454 shares, accounting for 26.90% of the company's total shares, making him the controlling shareholder [7] - The company stated that Yin Zhenglong's death would not affect the normal operation of the board of directors, and the management team would continue to perform their duties [9] Company Background - Shanhe Pharmaceutical Excipients was founded in April 2001 and specializes in the production, research, and sales of new pharmaceutical excipients, currently holding a leading position in the domestic market [11] - The company was successfully listed on the Shenzhen Stock Exchange in May 2015, with a current market value of approximately 3.28 billion yuan [11] - Under Yin Zhenglong's leadership, the company grew from a small local pharmaceutical factory to a publicly listed company [10] Financial Performance - For the first half of 2025, Shanhe Pharmaceutical Excipients reported a revenue of 471 million yuan, a year-on-year increase of 4.65%, while the net profit attributable to shareholders decreased by 2.61% to approximately 93 million yuan [12][13] - The company reported a significant increase in cash flow from operating activities, which rose by 108.53% compared to the previous year [13] - The basic earnings per share decreased by 2.44% to 0.40 yuan, while diluted earnings per share fell by 5.00% to 0.38 yuan [13]